 Mutation gene human myelogenous leukemia Heterogeneity protein expression blast cells patients acute myelogenous leukemia AML protein blasts certain AML patients others protein variants abnormal mobility gel electrophoresis and/or half-life sequence primary blast cells AML patients AML cell line point mutation codon valine residue aspartic acid wild type allele cells point mutations cysteine methionine cDNA blasts AML patient mutations present blast colonies single blast progenitor cells individual leukemia cells mutation alleles cDNAs blast samples patients prolonged protein detectable protein wild type heterogeneity expression cases genetic change sequence prolonged protein AML blasts reflect changes inherent model mutational inactivation evolution neoplasia selective advantage clonal outgrowth disease progression